PKI News and Press, PerkinElmer Inc. From 05/05/21

PerkinElmer, Inc. (PKI) Q1 2021 Results Earnings Conference Call May 04, 2021, 5:00 pm ET Company Participants Bryan Kipp - Vice President of Investor Relations Prahlad Singh - President, Chief Executive Officer Jamey Mock - Senior Vice President, Chief Financial Officer Conference Call Parti...

The following slide deck was published by PerkinElmer, Inc. in conjunction with their 2021 Q1 earnings call. For further details see: PerkinElmer, Inc. 2021 Q1 - Results - Earnings Call Presentation

PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will host a virtual Investor and Analyst Day on Thursday, June 24, 2021 from 8:30 a.m. to 12:00 p.m. ET. The virtual format will feature presentatio...

PerkinElmer (PKI): Q1 Non-GAAP EPS of $3.72 beats by $0.65; GAAP EPS of $3.37 beats by $0.78.Revenue of $1.31B (+100.7% Y/Y) beats by $100M.For the second quarter of 2021, the Company forecasts GAAP revenue of approximately $1.11 billion vs. $1.21B consensus, GAAP earnings per share from cont...

Revenue of $1.308 billion; 100% reported growth; 92% organic growth GAAP EPS from continuing operations of $3.37; Adjusted EPS of $3.72 Initiates Second Quarter and Raises Full-Year Revenue and Earnings Guidance PerkinElmer, Inc . (NYSE: PKI), a globa...

Thermo Fisher Scientific is a good-quality stock that is well-positioned to grow via M&A and organically in a growing industry. We outline the recent PPD, Inc. acquisition. We perform a DCF valuation to determine Thermo Fisher's fair value. For further details see: T...

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI), today announced that its T-SPOT ® Discovery SARS-CoV-2 kit will be used for T cell testing in th...

OXFORD, United Kingdom and MARLBOROUGH, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Oxford Immunotec, a global, high-growth diagnostics company part of PerkinElmer (NYSE: PKI) , today announced that its T-SPOT ® Discovery SARS-CoV-2 kit will be used for T cell testing in ...

How do we know what is going on #behindthescenes of a company?  According to Stock Traders Daily, a 20-year #financialindustry innovator, the best way to do this to to watch the price action in the stock. The Perkinelmer (NYSE: PKI) report below is a real world exam...

Solid biopharma demand, rising diagnostic trends, and the economic recovery will support a ‘healthy’ Q1 revenue growth argues UBS analyst Dan Brennan and the team in a Q1 2021 preview written on the sector of life sciences & diagnostic tools.The firm picks IQVIA Holdings ([[...